Skip to main navigation Skip to search Skip to main content

Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4

  • Joakim E Swedberg
  • , Laura V Nigon
  • , Janet C Reid
  • , Simon J de Veer
  • , Carina M Walpole
  • , Carson R Stephens
  • , Terry Walsh
  • , Thomas K Takayama
  • , John D Hooper
  • , Judith A Clements
  • , Ashley Maurice Buckle
  • , Jonathan M Harris

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Human kallikrein-related peptidase 4 (KLK4/prostase), a trypsin-like serine protease, is a potential target for prostate cancer treatment because of its proteolytic ability to activate many tumorigenic and metastatic pathways including the protease activated receptors (PARs). Currently there are no KLK4-specific small-molecule inhibitors available for therapeutic development. Here we re-engineer the naturally occurring sunflower trypsin inhibitor to selectively block the proteolytic activity of KLK4 and prevent stimulation of PAR activity in a cell-based system. The re-engineered inhibitor was designed using a combination of molecular modeling and sparse matrix substrate screening.
Original languageEnglish
Pages (from-to)633 - 643
Number of pages11
JournalChemistry & Biology
Volume16
Issue number6
DOIs
Publication statusPublished - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this